KRACIE HOLDINGS LTD has a total of 21 patent applications. It decreased the IP activity by 30.0%. Its first patent ever was published in 2010. It filed its patents most often in Japan, EPO (European Patent Office) and China. Its main competitors in its focus markets pharmaceuticals, foods and drinks and organic fine chemistry are NEUROBO PHARMACEUTICALS INC, TOKIWA PHYTOCHEMICAL CO LTD and HYPOXI CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 6 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | China | 2 | |
#4 | Republic of Korea | 2 | |
#5 | Taiwan | 2 | |
#6 | United States | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Foods | |
#4 | Special foods | |
#5 | Specific use of cosmetics | |
#6 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Inamasu Satoshi | 19 |
#2 | Watanabe Shimpei | 13 |
#3 | Yomoda Satoshi | 12 |
#4 | Arai Ayako | 10 |
#5 | Watanabe Mitsuhiro | 8 |
#6 | Takashina Yoko | 8 |
#7 | Kitahara Yuko | 7 |
#8 | Takajo Yuichi | 7 |
#9 | Ohno Akiko | 7 |
#10 | Kanatani Taisaku | 7 |
Publication | Filing date | Title |
---|---|---|
EP3597185A1 | Bile acid synthesis promoter, composition for promoting bile acid synthesis and food composition for promoting bile acid synthesis | |
TW201842904A | Inflammasome activation inhibitor comprising arctigenin and/or arctiin as main ingredients | |
JP2017195882A | Agent for removing undifferentiated cells | |
JP2018154568A | Glucagon inhibitor, glucagon inhibiting composition and glucagon inhibiting food composition | |
JP2018154569A | Agent for suppressing enlargement of lipid droplets in liver, composition for suppressing enlargement of lipid droplets in liver and food composition for suppressing enlargement of fat droplets in liver | |
KR20180105138A | Inflammation activator inhibitor | |
JP2017218410A | Composition for preventing or treating diabetes and composition for improving insulin resistance | |
JP2017186270A | Inhibitors of sebaceous cell activation | |
EP2623107A1 | Arctigenin-containing bardanae fructus extract and method for producing same |